Chief Executive Officer
CurrentWe are on a mission to increase pancreatic cancer survival through early detection. I lead a smart, passionate, lean team that has developed a blood test to detect pancreatic cancer at stage 1 and 2, when survival rates are dramatically higher. We are moving quickly to conduct studies to demonstrate the accuracy and clinical impact of the test before launching it in the second half of 2025.